FI952171A - Production of human monoclonal antibodies active against hepatitis B surface antigens - Google Patents

Production of human monoclonal antibodies active against hepatitis B surface antigens Download PDF

Info

Publication number
FI952171A
FI952171A FI952171A FI952171A FI952171A FI 952171 A FI952171 A FI 952171A FI 952171 A FI952171 A FI 952171A FI 952171 A FI952171 A FI 952171A FI 952171 A FI952171 A FI 952171A
Authority
FI
Finland
Prior art keywords
production
monoclonal antibodies
human monoclonal
active against
surface antigens
Prior art date
Application number
FI952171A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI952171A0 (en
Inventor
Lars G Ostberg
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of FI952171A0 publication Critical patent/FI952171A0/en
Publication of FI952171A publication Critical patent/FI952171A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI952171A 1992-11-06 1995-05-05 Production of human monoclonal antibodies active against hepatitis B surface antigens FI952171A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU9501328A HUT72546A (en) 1992-11-06 1992-11-06 Production of human monoclonal antibodies active against hepatitis b surface antigen
CZ951164A CZ116495A3 (en) 1992-11-06 1992-11-06 Production of human monoclonal antibodies against hepatitis b surface antigen
CA002147600A CA2147600A1 (en) 1992-11-06 1992-11-06 Production of human monoclonal antibodies active against hepatitis b surface antigen
PCT/US1992/009749 WO1994011495A1 (en) 1992-11-06 1992-11-06 Production of human monoclonal antibodies active against hepatitis b surface antigen

Publications (2)

Publication Number Publication Date
FI952171A0 FI952171A0 (en) 1995-05-05
FI952171A true FI952171A (en) 1995-07-05

Family

ID=27427228

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952171A FI952171A (en) 1992-11-06 1995-05-05 Production of human monoclonal antibodies active against hepatitis B surface antigens

Country Status (7)

Country Link
AU (1) AU684455B2 (en)
CA (1) CA2147600A1 (en)
CZ (1) CZ116495A3 (en)
FI (1) FI952171A (en)
HU (1) HUT72546A (en)
NO (1) NO951768L (en)
WO (1) WO1994011495A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2162370A1 (en) * 1993-05-10 1994-11-24 Willem Pieter Zeijlemaker Composition of antibodies against hepatitis b surface antigen
IL118626A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
IL118625A0 (en) 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibodies
EP0852951A1 (en) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stable lyophilized monoclonal or polyclonal antibodies containing pharmaceuticals
EP0893124A1 (en) * 1997-07-24 1999-01-27 Roche Diagnostics GmbH Pharmaceutical combination preparations comprising human monoclonal antibodies for the treatment of chronic hepatitis B and a virostatic substance
US7067247B2 (en) * 2000-03-31 2006-06-27 Ortho-Clinical Diagnostics, Inc. Hepatitis B virus surface protein
WO2013165972A2 (en) * 2012-04-30 2013-11-07 Cell Signaling Technology, Inc. Anti-hepatitis b virus antibodies and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346073A (en) * 1980-04-11 1982-08-24 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis B immune globulin used to inactivate hepatitis B virus in injectable biological products
CH652145A5 (en) * 1982-01-22 1985-10-31 Sandoz Ag METHOD FOR IN VITRO PRODUCTION OF HYBRID OMEN WHAT human monoclonal antibodies GENERATE.

Also Published As

Publication number Publication date
FI952171A0 (en) 1995-05-05
NO951768D0 (en) 1995-05-05
HUT72546A (en) 1996-05-28
HU9501328D0 (en) 1995-06-28
AU684455B2 (en) 1997-12-18
NO951768L (en) 1995-06-19
WO1994011495A1 (en) 1994-05-26
CA2147600A1 (en) 1994-05-26
CZ116495A3 (en) 1996-05-15
AU3177593A (en) 1994-06-08

Similar Documents

Publication Publication Date Title
DE69333706D1 (en) Surface reshaping of rodent antibodies
DK666389D0 (en) MONOCLONAL ANTIBODY
DK0835663T3 (en) Combined vaccines comprising Hepatitis B surface antigen and other antigens
DE69319662T2 (en) Monoclonal antibodies to GP130 protein
DK0531539T3 (en) Freeze-dried preparation of monoclonal antibodies
FI943635A0 (en) Planning, cloning, and expression of human interleukin monoclonal antibodies
IT8622630A0 (en) CROSS-REACTIVE AND CROSS-PROTECTIVE MONOCLONAL ANTIBODIES AGAINST SEROTYPES OF P. AERUGINOSA.
NO302176B1 (en) Process for the preparation of a monoclonal antibody and an antigen
GB9112836D0 (en) Production of monoclonal antibodies
IT1140050B (en) PRODUCTION OF HUMAN MONOCLONAL ANTIBODIES USING HUMAN HYBRIDOMES
IT1207589B (en) COMPOSITION OF CROSS-PROTECTIVE HUMAN MONOCLONAL ANTIBODIES.
FR2631239B1 (en) HUMAN MONOCLONAL ANTIBODIES AND HYBRIDOMA PRODUCING THE SAME
FI952171A (en) Production of human monoclonal antibodies active against hepatitis B surface antigens
DK717888A (en) MONOCLONAL ANTIBODIES
DK69690A (en) HUMAN ANTI-RH (D) MONOCLONAL ANTIBODIES
EP0511300A4 (en) Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
FI943524A0 (en) Monoclonal antibodies and anti-idiotype antibodies against hepatitis C virus
DK69590D0 (en) HUMAN ANTI-RH (D) MONOCLONAL ANTIBODIES
EP0672120A4 (en) Production of human monoclonal antibodies active against hepatitis b surface antigen.
FI944314A0 (en) Selective alteration of antibody immunogenicity
DK370089A (en) ANTI-UROKINASE MONOCLONAL ANTIBODIES
AU9143991A (en) Monoclonal antibody op-g2 and method of use
PL314469A1 (en) Production of human monoclonal antibodies against surface antigene of b hepatitis
AU3432389A (en) Human monoclonal antibodies against rabies virus
IT8721792A0 (en) METHOD FOR THE IMMUNOLOCALIZATION OF ANTIGENS WITH THE USE OF ANTIBODIES DIRECTED AGAINST EPITOPES OF A NON-GLUDIC NATURE